Fig. 1From: Is Afamin a novel biomarker for gestational diabetes mellitus? A pilot studyAfamin concentrations in the first trimester cohort (between gestational day 8 and 98). Serum concentrations of afamin among patients with gestational diabetes mellitus (GDM) treated with insulin (iGDM; n = 34), treated with dietary intervention (dGDM; n = 25) and control subjects (n = 51) adjusted for gestational age and body-mass-index (BMI)Back to article page